PharmacovigilanceOfficial

MHRA marks #MedSafetyWeek with Yellow Card login and app upgrades

🇬🇧 MHRA Drug Safety Update · Mon 26 Oct 2026

The UK regulator's eleventh annual campaign runs from 2 to 8 November 2026, urging suspected side effect and device incident reporting, alongside NHS login integration and a progressive web app.

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that its annual #MedSafetyWeek campaign will run from 2 to 8 November 2026. This year's theme is 'Side effects: don't ignore them, report them!' The agency describes it as the eleventh annual social media campaign.

The MHRA says the Yellow Card scheme depends on reports from healthcare professionals and patients. These allow it to identify and monitor potential safety concerns with medicines, devices, vaccines, blood products and e-cigarettes. Yellow Card can also be used to report concerns about defective or falsified products. Clinicians are reminded that only a suspicion is needed to submit a report, and that they should respond to any MHRA requests for follow-up information.

Healthcare professionals are asked to support the campaign using new materials on the Yellow Card website, including posters, digital screens, waiting room materials and social media assets. The MHRA also suggests signposting patients to the website or app, sharing content with hashtags such as #MHRAYellowCard and #MedSafetyWeek, and pointing colleagues to its Yellow Card e-learning modules. These include a recently CPD-accredited, free British Pharmacological Society Assessment.

The notice also lists changes to the Yellow Card website and app. Integration with NHS login now lets users create a new Yellow Card account or link an existing one, which the MHRA says simplifies sign-in. The Yellow Card app is now a progressive web app that mirrors the website to give a consistent experience. The source text is cut off partway through the description of the app's additional features, so further detail is not available here.

For medicines, reports can be submitted via the Yellow Card website, the app, or some clinical IT systems: EMIS, SystmOne, Vision, MiDatabank and Ulysses. For medical device incidents, the route depends on the nation. England and Wales use the Yellow Card website or app, Scotland uses the Incident Reporting & Investigation Centre (IRIC) and local incident systems, and Northern Ireland uses the Yellow Card website.

What it means for your team

  • PV teams may wish to align internal communications and staff reminders with the 2 to 8 November campaign window and the MHRA's hashtags and materials.
  • Check whether NHS login integration and the progressive web app change how staff or patients access Yellow Card in your reporting procedures or training.
  • Remind reporters to include medical history, concomitant medication, onset timing and treatment dates, and to respond promptly to MHRA follow-up requests.
  • Device teams should note the different reporting routes in England and Wales, Scotland and Northern Ireland.

Official source: MHRA Drug Safety Update ↗

Article written by VigiEye from the official source (MHRA Drug Safety Update). AI-assisted; check the source before acting.

More Pharmacovigilance All →